Skip to main content
. 2022 Jan 2;36(4):1066–1077. doi: 10.1038/s41375-021-01488-8

Fig. 2. PFS subdivided by ISS stage.

Fig. 2

PFS subdivided by ISS stage in the (A) total–non-frail subgroup and (B) frail subgroup. PFS progression-free survival, ISS International Staging System, D-Rd daratumumab plus lenalidomide/dexamethasone, Rd lenalidomide/dexamethasone, HR hazard ratio, CI confidence interval.